Myc - MYC proto-oncogene, bHLH transcription factor Gene

Also Known as mMyc; c-myc; RNCMYC

Species: Rattus norvegicus

Gene Type: protein coding

Gene ID: 24577

About Myc

Primary_assembly 7: 93,593,705-93,598,630 forward strand.mRatBN7.2:CM026980.1

This gene has 1 transcript (splice variant), 217 orthologues, 4 paralogues and is associated with 102 phenotypes. Biased expression in Spleen (RPKM 98.), Thymus (RPKM 64.5) and 9 other tissues.

Summary

The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, Apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma, in human. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini, in human and mouse. Rat mRNA also has a similarly placed CUG upstream of the AUG start site, suggesting that it may also produce two Myc proteins. [provided by RefSeq, Jul 2008]

Myc Products (1)

mRNA	Protein	Name
NM_012603.2	NP_036735.2	myc proto-oncogene protein

Gene Ontology

Molecular Function
Biological Process

Molecular Function GO Annotation	Evidence	References	Source
enables DNA binding	IDA IDA: Inferred from direct assay	11799123	RGD
enables DNA-binding transcription factor activity	IDA IDA: Inferred from direct assay	15139290	RGD
enables DNA-binding transcription factor activity	IMP IMP: Inferred from mutant phenotype	17341548	RGD
enables double-stranded DNA binding	IDA IDA: Inferred from direct assay	15139290	RGD
enables protein binding	IPI IPI: Inferred from physical interaction	17334388	RGD
enables protein-containing complex binding	IPI IPI: Inferred from physical interaction	17341548	RGD
enables sequence-specific DNA binding	IDA IDA: Inferred from direct assay	15139290	RGD

Biological Process GO Annotation	Evidence	References	Source
involved in DNA-templated transcription	IDA IDA: Inferred from direct assay	15139290	RGD
involved in DNA-templated transcription initiation	IDA IDA: Inferred from direct assay	3306601	RGD
involved in G0 to G1 transition	IEP IEP: Inferred from expression pattern	23119170	RGD
involved in amino acid transport	IMP IMP: Inferred from mutant phenotype	22842522	RGD
involved in cellular response to angiotensin	IEP IEP: Inferred from expression pattern	17886230	RGD
involved in cellular response to arsenite(3-)	IEP IEP: Inferred from expression pattern	9848127	RGD
involved in cellular response to carbohydrate stimulus	IEP IEP: Inferred from expression pattern	20694826	RGD
involved in cellular response to cycloheximide	IEP IEP: Inferred from expression pattern	11550711	RGD
involved in cellular response to cytokine stimulus	IEP IEP: Inferred from expression pattern	11687580	RGD
involved in cellular response to dimethyl sulfoxide	IEP IEP: Inferred from expression pattern	12873812	RGD
involved in cellular response to endothelin	IEP IEP: Inferred from expression pattern	16365184	RGD
involved in cellular response to epidermal growth factor stimulus	IEP IEP: Inferred from expression pattern	7524476	RGD
involved in cellular response to estrogen stimulus	IEP IEP: Inferred from expression pattern	21980073	RGD
involved in cellular response to fibroblast growth factor stimulus	IEP IEP: Inferred from expression pattern	7524476	RGD
involved in cellular response to growth hormone stimulus	IEP IEP: Inferred from expression pattern	11550711	RGD
involved in cellular response to hydrostatic pressure	IEP IEP: Inferred from expression pattern	22644739	RGD
involved in cellular response to insulin stimulus	IEP IEP: Inferred from expression pattern	2200903	RGD
involved in cellular response to interleukin-1	IEP IEP: Inferred from expression pattern	22706317	RGD
involved in cellular response to lectin	IEP IEP: Inferred from expression pattern	2200903	RGD
involved in cellular response to organic cyclic compound	IEP IEP: Inferred from expression pattern	21980073	RGD
involved in cellular response to phorbol 13-acetate 12-myristate	IEP IEP: Inferred from expression pattern	2200903	RGD
involved in cellular response to platelet-derived growth factor stimulus	IEP IEP: Inferred from expression pattern	7524476	RGD
involved in cellular response to prolactin	IEP IEP: Inferred from expression pattern	9296381	RGD
involved in cellular response to putrescine	IEP IEP: Inferred from expression pattern	8048943	RGD
involved in cellular response to retinoic acid	IEP IEP: Inferred from expression pattern	12873812	RGD
involved in cellular response to testosterone stimulus	IEP IEP: Inferred from expression pattern	7721656	RGD
involved in cellular response to type II interferon	IEP IEP: Inferred from expression pattern	7524476	RGD
involved in cellular response to xenobiotic stimulus	IEP IEP: Inferred from expression pattern	17886230	RGD
involved in glucose metabolic process	IMP IMP: Inferred from mutant phenotype	12480946	RGD
involved in hypothalamus development	IEP IEP: Inferred from expression pattern	23291449	RGD
involved in in utero embryonic development	IEP IEP: Inferred from expression pattern	23077551	RGD
involved in inner mitochondrial membrane organization	IMP IMP: Inferred from mutant phenotype	22629444	RGD
involved in lactic acid secretion	IMP IMP: Inferred from mutant phenotype	22842522	RGD
involved in liver regeneration	IEP IEP: Inferred from expression pattern	3335218	RGD
involved in myoblast proliferation	IEP IEP: Inferred from expression pattern	2425941	RGD
involved in negative regulation of D-glucose import	IMP IMP: Inferred from mutant phenotype	22842522	RGD
involved in negative regulation of epithelial cell apoptotic process	IMP IMP: Inferred from mutant phenotype	22100782	RGD
involved in negative regulation of gene expression	IMP IMP: Inferred from mutant phenotype	23349663	RGD
involved in negative regulation of transcription by RNA polymerase II	IMP IMP: Inferred from mutant phenotype	9924025	RGD
involved in ovarian follicle development	IEP IEP: Inferred from expression pattern	9071960	RGD
involved in positive regulation of ATP biosynthetic process	IMP IMP: Inferred from mutant phenotype	22629444	RGD
involved in positive regulation of DNA-templated transcription	IDA IDA: Inferred from direct assay	18818310	RGD
involved in positive regulation of cell cycle	IMP IMP: Inferred from mutant phenotype	22210745	RGD
involved in positive regulation of cell population proliferation	IGI IGI: Inferred from genetic interaction	21980073	RGD
involved in positive regulation of cellular respiration	IMP IMP: Inferred from mutant phenotype	22842522	RGD
involved in positive regulation of fibroblast proliferation	IMP IMP: Inferred from mutant phenotype	22842522	RGD
involved in positive regulation of glial cell proliferation	IMP IMP: Inferred from mutant phenotype	9316053	RGD
involved in positive regulation of glycolytic process	IMP IMP: Inferred from mutant phenotype	22842522	RGD
involved in positive regulation of mitochondrial membrane potential	IMP IMP: Inferred from mutant phenotype	22629444	RGD
involved in positive regulation of oxidative phosphorylation	IMP IMP: Inferred from mutant phenotype	18414044	RGD
involved in positive regulation of smooth muscle cell migration	IMP IMP: Inferred from mutant phenotype	8421701	RGD
involved in positive regulation of smooth muscle cell proliferation	IMP IMP: Inferred from mutant phenotype	8113414	RGD
involved in positive regulation of transcription by RNA polymerase II	IMP IMP: Inferred from mutant phenotype	12480946	RGD
involved in pyruvate transport	IMP IMP: Inferred from mutant phenotype	22842522	RGD
involved in re-entry into mitotic cell cycle	IMP IMP: Inferred from mutant phenotype	18414044	RGD
involved in regulation of DNA-templated transcription	IDA IDA: Inferred from direct assay	11799123	RGD
involved in regulation of DNA-templated transcription	IMP IMP: Inferred from mutant phenotype	17341548	RGD
involved in regulation of mitotic cell cycle	IMP IMP: Inferred from mutant phenotype	12070150	RGD
involved in regulation of oxidative phosphorylation	IMP IMP: Inferred from mutant phenotype	22629444	RGD
involved in response to estradiol	IEP IEP: Inferred from expression pattern	23027806	RGD
involved in response to ethanol	IEP IEP: Inferred from expression pattern	12370848	RGD
involved in response to human chorionic gonadotropin	IEP IEP: Inferred from expression pattern	9071960	RGD
involved in transcription by RNA polymerase II	IDA IDA: Inferred from direct assay	15139290	RGD

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Myc Protein Structure

Myc_N

bHLHzip_c-Myc

0
100
200
300
400
453 a.a.

Protein Preferred Names	Protein Names
myc proto-oncogene protein	Avian myelocytomatosis viral (v-myc) oncogene homolog myelocytomatosis oncogene myelocytomatosis viral oncogene homolog proto-oncogene c-Myc transcription factor p64 v-myc avian myelocytomatosis viral oncogene homolog

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-17381A	Idarubicin		99.89%	Yes

Clinical Phase

Bioactive Molecules (21)

Cat. No.	Product Name	Effect	Purity	Phase
HY-172113	H122		98.33%	Phase 4
HY-12863	Pelabresib	Inhibitor	99.95%	Phase 3
HY-19763	Ifupinostat		99.30%	Phase 3
HY-W013724	Inosine-5'-diphosphate disodium		99.08%	Phase 3
HY-111784	Inobrodib	Inhibitor	99.95%	Phase 2
HY-153356	MRT-2359	Inducer	99.98%	Phase 2
HY-X0009	Tambiciclib		99.68%	Phase 2
HY-126400	Tocopherols	Inhibitor	98.6%	Phase 2
HY-109050	Alobresib	Inhibitor	98.04%	Phase 2
HY-185051	OTX-2002		/	Phase 2
HY-10212A	BIIB021 mesylate		/	Phase 2
HY-149451	SYHA1815	Inhibitor	/	Phase 2
HY-16291	APTO-253		99.74%	Phase 1
HY-145898	WBC100	Inhibitor	95.01%	Phase 1
HY-123954	BTX-A51		98.99%	Phase 1
HY-136938	NEO2734	Inhibitor	99.63%	Phase 1
HY-16366	Briciclib		99.45%	Phase 1
HY-103019B	(-)-Enitociclib		99.85%	Phase 1
HY-117286	(S)-JQ-35		99.46%	Phase 1
HY-112316	BAY1238097	Inhibitor	99.02%	Phase 1
HY-103019BR	(-)-Enitociclib (Standard)		/	Phase 1

Pre-clinical Phase

Bioactive Molecules (336)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-12702	10058-F4	Inhibitor	99.90%	Unkown
HY-80013	THZ1	Inhibitor	99.84%	Unkown
HY-107738	Guggulsterone		99.83%	Unkown
HY-15594A	Phen-DC3 Trifluoromethanesulfonate		98.64%	Unkown
HY-153367	FHD-609		98.95%	Unkown
HY-134582	dCBP-1		99.37%	Unkown
HY-13241	Ralimetinib dimesylate		99.97%	Unkown
HY-112929	DT-061	Activator	99.95%	Unkown
HY-103019	Enitociclib		99.89%	Unkown
HY-126477	NNK		99.97%	Unkown
HY-19735	KJ Pyr 9	Inhibitor	99.24%	Unkown
HY-120929	BI8622	Inhibitor	98.16%	Unkown
HY-129937A	GNE-987	Inhibitor	99.98%	Unkown
HY-162318	MYC degrader 1	Degrader	99.61%	Unkown
HY-139361	Sulfopin	Inhibitor	99.82%	Unkown
HY-N0330	Momordin Ic		99.78%	Unkown
HY-N3005	Britannin		99.93%	Unkown
HY-124675	MYCMI-6		98.57%	Unkown
HY-N2068	Didymin	Inducer	99.96%	Unkown
HY-134761	EN4	Inhibitor	96.29%	Unkown
HY-129600	MYCi361	Inhibitor	99.95%	Unkown
HY-174228	I3IN-002		99.35%	Unkown
HY-145669	DIF-3		99.84%	Unkown
HY-N0704	Agrimol B		99.75%	Unkown
HY-124447	BTYNB		98.0%	Unkown
HY-153713	MYC-RIBOTAC		98.17%	Unkown
HY-123941	FKBP12 PROTAC dTAG-7		99.47%	Unkown
HY-172158	ALKBH5-IN-5		99.66%	Unkown
HY-80013A	THZ1 Hydrochloride	Inhibitor	99.06%	Unkown
HY-100996	10074-G5	Inhibitor	99.63%	Unkown
HY-139330	MGH-CP1	Inducer	99.56%	Unkown
HY-112296	T025		99.64%	Unkown
HY-114208A	BI-9321 trihydrochloride	Antagonist	99.83%	Unkown
HY-120028	GNE-207	Inhibitor	99.94%	Unkown
HY-P0312	c-Myc Peptide TFA		99.97%	Unkown
HY-N2534	Karanjin		99.96%	Unkown
HY-148837	GT19630		98.85%	Unkown
HY-149230	USP28-IN-4	Inhibitor	98.86%	Unkown
HY-159059	Ganoderma lucidum polysaccharide		41.20%	Unkown
HY-100669	Mycro 3	Inhibitor	98.11%	Unkown
HY-13250	Silvestrol aglycone		99.95%	Unkown
HY-173523	KI-CDK9d-32		99.03%	Unkown
HY-103019A	(±)-Enitociclib		99.23%	Unkown
HY-144878	VPC-70619	Inhibitor	99.93%	Unkown
HY-12703	KSI-3716	Inhibitor	98.98%	Unkown
HY-135691	hnRNPK-IN-1		97.0%	Unkown
HY-133121	WDR5-IN-1		98.0%	Unkown
HY-107194	NSC12		/	Unkown
HY-173552	TCIP3	Inhibitor	99.30%	Unkown
HY-19759	SRT 2183		98.06%	Unkown
HY-149209	LL-K8-22		99.06%	Unkown
HY-162919	YK-2168		98.05%	Unkown
HY-150259	MDEG-541	Degrader	98.68%	Unkown
HY-153728	WM-586	Inhibitor	98.71%	Unkown
HY-128775	JHU395	Inducer	99.69%	Unkown
HY-171770	dAurAB5		99.03%	Unkown
HY-172825	KL4-219A	Degrader	99.85%	Unkown
HY-122683	sAJM589	Inhibitor	99.47%	Unkown
HY-112440	HZX-02-059	Inhibitor	99.40%	Unkown
HY-153278	Q901	Inhibitor	98.38%	Unkown
HY-160409	TopBP1-IN-1		98.35%	Unkown
HY-22445	MY05	Inhibitor	99.34%	Unkown
HY-N10790	RA-V		99.85%	Unkown
HY-112056	DIM-C-pPhCO2Me		99.29%	Unkown
HY-114189	GW284543	Inhibitor	99.94%	Unkown
HY-163828	PPA24		98.09%	Unkown
HY-N0863	Methyl protodioscin		99.67%	Unkown
HY-N8146	Bruceantinol	Inhibitor	98.89%	Unkown
HY-125236	ZEN-3694		99.85%	Unkown
HY-13032B	Molibresib besylate		97.04%	Unkown
HY-153357	NRX-0492		98.30%	Unkown
HY-168439	HLB-0532259		98.30%	Unkown
HY-147291	VPC-70063		99.92%	Unkown
HY-153278A	Q901 TFA	Inhibitor	/	Unkown
HY-N10549	Gigantol		99.79%	Unkown
HY-154847	WM-662	Inhibitor	99.48%	Unkown
HY-119271	CMLD010509		99.11%	Unkown
HY-148836	c-Myc inhibitor 6	Inhibitor	98.04%	Unkown
HY-149873	Anticancer agent 126	Inhibitor	98.05%	Unkown
HY-N4184	Licoflavone B	Inhibitor	99.86%	Unkown
HY-W1126235	DS02312223	Activator	98.24%	Unkown
HY-113225S5	Guanosine triphosphate-13C10 dilithium		99.4%	Unkown
HY-103038	ML327	Inhibitor	98.02%	Unkown
HY-112799	DK419	Inhibitor	99.86%	Unkown
HY-115881	SR-1114	Degrader	99.04%	Unkown
HY-137849	RK-582	Inhibitor	98.05%	Unkown
HY-115590	JP-11646		98.74%	Unkown
HY-111411	IZCZ-3	Inhibitor	99.74%	Unkown
HY-117203A	CDK12-IN-E9	Inhibitor	99.71%	Unkown
HY-113225S3	Guanosine triphosphate-15N5 dilithium		99.2%	Unkown
HY-124811	IRES-C11	Inhibitor	98.01%	Unkown
HY-126979	Mycro2	Inhibitor	99.81%	Unkown
HY-134333	ICCB280	Activator	98.14%	Unkown
HY-162318A	MYC degrader 1 TFA	Degrader	99.36%	Unkown
HY-168685	c-Myc ligand 1	Inhibitor	99.93%	Unkown
HY-N6747	Stauprimide	Inhibitor	99.45%	Unkown
HY-145748	SYUIQ-5		99.03%	Unkown
HY-150109A	Purinostat	Inhibitor	98.04%	Unkown
HY-RS08877	MYC Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-133131	PROTAC BRD4 Degrader-1	Inhibitor	99.31%	Unkown
HY-124129	10074-A4	Inhibitor	98.22%	Unkown
HY-168428	CHI-KAT8i5		98.00%	Unkown
HY-168518	PROTAC CDK9 degrader-9		99.25%	Unkown
HY-173119	SKLB-D18		98.06%	Unkown
HY-133138	Pomalidomide-PEG1-azide		95.03%	Unkown
HY-111522	RK-9123016	Inhibitor	99.65%	Unkown
HY-121418	Lusianthridin	Inhibitor	99.21%	Unkown
HY-123955	Casein Kinase inhibitor A86		99.26%	Unkown
HY-148452	eIF4A3-IN-18	Inhibitor	99.58%	Unkown
HY-156084	LL-K9-3		99.2%	Unkown
HY-162470	DBPR728	Inhibitor	98.11%	Unkown
HY-172920	Wnt/β-catenin-IN-6		98.34%	Unkown
HY-176142	YX0798		98.90%	Unkown
HY-N11576	Secalonic acid D		99.63%	Unkown
HY-N2276	Nodakenetin	Activator	99.66%	Unkown
HY-X0009A	Tambiciclib dimaleate		99.53%	Unkown
HY-138635	PROTAC BRD4 Degrader linker conjugate-3	Inhibitor	98.54%	Unkown
HY-107425A	cis-MZ 1		99.8%	Unkown
HY-113225S2	Guanosine triphosphate-13C dilithium		98.2%	Unkown
HY-125978	JY-3-094	Inhibitor	97.04%	Unkown
HY-134975	NY2267	Inhibitor	98.53%	Unkown
HY-147651	β-catenin-IN-4	Inhibitor	99.84%	Unkown
HY-148446	eIF4A3-IN-12	Inhibitor	99.70%	Unkown
HY-149229	USP28-IN-3	Inhibitor	98.26%	Unkown
HY-162469	6K465	Inhibitor	98.61%	Unkown
HY-170820	XYD049	Inhibitor	99.46%	Unkown
HY-171769	dAurAB2	Degrader	98.61%	Unkown
HY-173212	PLK1-IN-13		98.02%	Unkown
HY-RS08878	Myc Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-D2188	IMP-2373	Chemical	99.58%	Unkown
HY-112316A	(R)-BAY1238097		98.20%	Unkown
HY-138632	PROTAC BRD4 Degrader linker conjugate-1	Degrader	98.98%	Unkown
HY-101280	LB-60-OF61	Inhibitor	99.39%	Unkown
HY-107425B	cis-MZ 1 hydrate		99.0%	Unkown
HY-112929B	(1S,2S,3R)-DT-061		99.77%	Unkown
HY-113225S1	Guanosine triphosphate-13C10,15N5 tetraammonium solution (100 mM)		99.98%	Unkown
HY-113225S4	Guanosine triphosphate-15N5,d14 dilithium		98.4%	Unkown
HY-132941	CFT-2718		99.87%	Unkown
HY-139620	MS83	Degrader	/	Unkown
HY-147261	B026	Inhibitor	/	Unkown
HY-147973	IZTZ-1		99.47%	Unkown
HY-148443	eIF4A3-IN-9	Inhibitor	99.71%	Unkown
HY-148444	eIF4A3-IN-10	Inhibitor	97.87%	Unkown
HY-148445	eIF4A3-IN-11	Inhibitor	99.24%	Unkown
HY-148448	eIF4A3-IN-14	Inhibitor	99.81%	Unkown
HY-148449	eIF4A3-IN-15	Inhibitor	/	Unkown
HY-148450	eIF4A3-IN-16	Inhibitor	99.96%	Unkown
HY-148451	eIF4A3-IN-17	Inhibitor	99.56%	Unkown
HY-151884	FUBP1-IN-2	Inhibitor	99.26%	Unkown
HY-162796	TS-2		98.27%	Unkown
HY-168201	MJP6412		95.90%	Unkown
HY-185310	MKI-2	Inhibitor	/	Unkown
HY-W011616	Cardionogen 1	Inhibitor	99.21%	Unkown
HY-174577	Human MYC mRNA		86.9%	Unkown
HY-N19791	6-Methoxymellein	Inhibitor	97.69%	Unkown
HY-101280A	LB-60-OF61 hydrochloride	Inhibitor	/	Unkown
HY-128761	CBP/p300-IN-2	Inhibitor	/	Unkown
HY-138633	PROTAC BRD4 Degrader linker conjugate-2	Degrader	99.75%	Unkown
HY-158062	LC-1-40		/	Unkown
HY-182242	AGB-374	Inhibitor	/	Unkown
HY-111165	SNX-7081		/	Unkown
HY-111537	rel-AZ5576	Inhibitor	/	Unkown
HY-104072	BRD4-IN-3	Inhibitor	/	Unkown
HY-114189A	GW284543 hydrochloride	Inhibitor	/	Unkown
HY-114208	BI-9321	Antagonist	/	Unkown
HY-115541	BRD4-IN-41	Inhibitor	/	Unkown
HY-115663	C620-0696		/	Unkown
HY-115797	LQFM030		/	Unkown
HY-115832	Ap44mSe		/	Unkown
HY-120750	A 62176 hydrochloride		/	Unkown
HY-121444	MYRA-A		/	Unkown
HY-121917	Ro 31-7837		/	Unkown
HY-122352	OSU-03013		/	Unkown
HY-122686	USP25/28-IN-2		/	Unkown
HY-122860	SKLB-C05		/	Unkown
HY-124791	MMRi6		99.70%	Unkown
HY-124792	MRLB-223		/	Unkown
HY-125090	PHA-680626		/	Unkown
HY-125636	Mycro1	Inhibitor	/	Unkown
HY-125718	MLS-2384 free base		/	Unkown
HY-129341	WP1193	Inhibitor	/	Unkown
HY-129937	(S)-GNE-987	Inhibitor	/	Unkown
HY-131203	PROTAC BRD4 Degrader-6		/	Unkown
HY-136794	SB-284851-BT	Inhibitor	/	Unkown
HY-138637	PROTAC BRD4 Degrader-14	Inhibitor	/	Unkown
HY-139885	c-Myc inhibitor 4	Inhibitor	/	Unkown
HY-141666	MYC-IN-2	Inhibitor	/	Unkown
HY-143235	BRD4 Inhibitor-15		/	Unkown
HY-143471	WNY0824		/	Unkown
HY-145843	c-Myc inhibitor 5	Inhibitor	/	Unkown
HY-146445	P300 bromodomain-IN-1	Inhibitor	/	Unkown
HY-148838	c-Myc inhibitor 8	Inhibitor	/	Unkown
HY-148839	c-Myc inhibitor 9	Inhibitor	/	Unkown
HY-149101	Inosine-5'-diphosphate		/	Unkown
HY-149228	USP28-IN-2	Inhibitor	/	Unkown
HY-149495	CP-07	Degrader	/	Unkown
HY-149513	EP12		/	Unkown
HY-149735	BET-IN-20		/	Unkown
HY-150683	NC-III-49-1	Inhibitor	/	Unkown
HY-150684	GXH-II-052	Inhibitor	/	Unkown
HY-151471	Anticancer agent 84	Inhibitor	/	Unkown
HY-15163A	Zotiraciclib hydrochloride	Inhibitor	/	Unkown
HY-152471	Eleven-Nineteen-Leukemia Protein IN-3	Inhibitor	/	Unkown
HY-153414	GXF-111		/	Unkown
HY-154839	c-Myc inhibitor 10	Inhibitor	/	Unkown
HY-155153	CDK9-IN-24		/	Unkown
HY-155371	BT-PROTAC		/	Unkown
HY-155507	c-Myc inhibitor 11	Inhibitor	/	Unkown
HY-155508	c-Myc inhibitor 12	Inhibitor	/	Unkown
HY-156673	m-Se3	Inhibitor	/	Unkown
HY-15947G	Ravoxertinib (GMP)	Inhibitor	/	Unkown
HY-159728	PROTAC PRMT3 degrader 1	Degrader	/	Unkown
HY-159756B	KI-MS2-008	Inhibitor	/	Unkown
HY-160549	c-Myc inhibitor 14	Inhibitor	/	Unkown
HY-160689	GW694590A	Inhibitor	/	Unkown
HY-161826	Antitumor agent-174	Inhibitor	/	Unkown
HY-162294	c-Myc inhibitor 13	Inhibitor	/	Unkown
HY-162460	ERK1/2 inhibitor 10	Inhibitor	/	Unkown
HY-16291A	APTO-253 hydrochloride	Inhibitor	/	Unkown
HY-163108	ATAD2-IN-1		/	Unkown
HY-16366A	Briciclib sodium		/	Unkown
HY-163774	WDR5-MYC-IN-1	Inhibitor	/	Unkown
HY-165606	SB-T-1214	Inducer	/	Unkown
HY-168483	FTO-IN-13		/	Unkown
HY-168684	E3 Ligase Ligand-linker Conjugate 136		/	Unkown
HY-168886	Anticancer agent 263	Ligand	/	Unkown
HY-169348	β-catenin-IN-8	Inhibitor	/	Unkown
HY-169378	CSI86	Degrader	/	Unkown
HY-169921	c-Myc inhibitor 15	Inhibitor	/	Unkown
HY-170595	PROTAC LZK degrader 1		/	Unkown
HY-170841	HDAC3/BRD4-IN-1	Inhibitor	/	Unkown
HY-170900	SJ44236		/	Unkown
HY-171334A	P1D-34		/	Unkown
HY-171788	NMT-IN-8	Inhibitor	/	Unkown
HY-172368	PROTAC CARM1/IKZF3 degrader-1		/	Unkown
HY-172399	FTO-IN-14		/	Unkown
HY-172614	RK-0080552		/	Unkown
HY-173062	BRD4 Inhibitor-40	Inhibitor	/	Unkown
HY-173467	MTP3	Degrader	/	Unkown
HY-173469	MYC ligand-1	Degrader	/	Unkown
HY-174255	WDR5-MYC-IN-2	Inhibitor	/	Unkown
HY-174403	c-MYC/BCL2 ligand 1 iodide		/	Unkown
HY-175033	BRD4-IN-11	Inhibitor	/	Unkown
HY-175164	SVC112		/	Unkown
HY-175265	PQ32		/	Unkown
HY-175771	STAT3-IN-46	Inhibitor	/	Unkown
HY-175850	GSK-3β-IN-28		/	Unkown
HY-175964	MYC-MAX-IN-1	Ligand	/	Unkown
HY-176019	Methylcarbamyl PAF C-8		/	Unkown
HY-176066A	c-Myc inhibitor 16 iodide		/	Unkown
HY-176488	Y-99	Inhibitor	/	Unkown
HY-176501	FKBP12 ligand-2		/	Unkown
HY-176502	FKBP12 ligand-3		/	Unkown
HY-177744	GSPT2 degrader-1		/	Unkown
HY-177872	GQC-05	Inducer	/	Unkown
HY-178039	CDK9-IN-42		/	Unkown
HY-178045	MYC-IN-4	Inhibitor	/	Unkown
HY-178172	AF9/ENL-DOT1L PPI-IN-1	Inhibitor	/	Unkown
HY-178446	METTL3-IN-11	Inhibitor	/	Unkown
HY-178499	CDK9-IN-44	Inhibitor	/	Unkown
HY-178858	PROTAC FLT3/CHK1 Degrader-1		/	Unkown
HY-178909	Y502-2304		/	Unkown
HY-178984	PI3Kα-IN-28		/	Unkown
HY-179023	CDK9-IN-45		/	Unkown
HY-179267	FTO-IN-16		/	Unkown
HY-179525	DL78		99.00%	Unkown
HY-179588	PROTAC BET Degrader-14		/	Unkown
HY-179734	PROTAC BRD4 Degrader-41		/	Unkown
HY-180124	CDK8-IN-20		/	Unkown
HY-180150	PROTAC BRD4 Degrader-42		/	Unkown
HY-180355	SY-5102		/	Unkown
HY-180886	ZD-1-186	Inhibitor	/	Unkown
HY-181078	Cephalotaxine-ester-(R)-1-ethoxy-3-mercaptopropan-2-ol-Ph(3,4OMe)		/	Unkown
HY-181234	Y502-3888		/	Unkown
HY-181505	BRD4-IN-12		/	Unkown
HY-181514	STAT3-IN-53		/	Unkown
HY-181541	HIT211504993		/	Unkown
HY-181627	ETC-501		97.40%	Unkown
HY-181669	P300-IN-6	Inhibitor	/	Unkown
HY-181670	WH23		/	Unkown
HY-181729	PROTAC BET Degrader-15		/	Unkown
HY-181758	PROTAC CBP/p300/BRD4 Degrader-1		/	Unkown
HY-181930	TNIK-IN-10		/	Unkown
HY-181957	KB528		/	Unkown
HY-182036	KWZL-7f15		/	Unkown
HY-182055	Anticancer agent 309		/	Unkown
HY-182241	JR4-187		/	Unkown
HY-182681	AV-9606-129	Inhibitor	/	Unkown
HY-182706	NSC 373981	Inhibitor	/	Unkown
HY-182801	PROTAC BRD4 Degrader-46		/	Unkown
HY-182958	Hsp70TAC BRD4 Degrader-1		/	Unkown
HY-183070	CXJ2080		/	Unkown
HY-183073	TZ1104		/	Unkown
HY-183273	BRD4/AKT-IN-1		/	Unkown
HY-183390	Scopadulciol		/	Unkown
HY-183643	RUVBL1/2-IN-1		/	Unkown
HY-183710	CDK9-IN-50		/	Unkown
HY-183770	LCI40	Inhibitor	/	Unkown
HY-183825	Eleven-Nineteen-Leukemia Protein IN-4	Inhibitor	/	Unkown
HY-183984	G-quadruplex ligand 6	Ligand	/	Unkown
HY-183992	CZL-149	Inhibitor	/	Unkown
HY-184176	DBCO-PEG3-AP1867	Chemical	/	Unkown
HY-184335	PROTAC BET Degrader-18		/	Unkown
HY-184342	SYC-2863		/	Unkown
HY-184556	dCBP-30		/	Unkown
HY-184891	W1307	Inhibitor	/	Unkown
HY-184896	XYD113	Inhibitor	/	Unkown
HY-184932	PIN1-IN-7		/	Unkown
HY-185310A	MKI-2 hydrochloride	Inhibitor	99.57%	Unkown
HY-185697	dIRF4-2	Inhibitor	/	Unkown
HY-186146	SGI-1776-VHL-02		96.67%	Unkown
HY-186247	N-Myc-IN-1		/	Unkown
HY-187207	BRD4-BD1-IN-4		/	Unkown
HY-N15121	4-O-Methyl-ascochlorin		/	Unkown
HY-P10418	VGN50	Inhibitor	/	Unkown
HY-P11948	c-Myc NLS		/	Unkown
HY-RS08879	Myc Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W013724S	Inosine-5'-diphosphate-15N4 dilithium	Inhibitor	/	Unkown
HY-W800535	Cryptolepine		/	Unkown
HY-103019AR	(±)-Enitociclib (Standard)		/	Unkown
HY-113225	Guanosine triphosphate		/	Unkown
HY-115569	DC-34	Inhibitor	/	Unkown
HY-119271A	(-)-CMLD010509		/	Unkown
HY-130369	NSC10010 hydrochloride		/	Unkown
HY-139118	NSC308848		/	Unkown
HY-168326	Antiproliferative agent-64	Inhibitor	/	Unkown
HY-173172	MG-002		/	Unkown
HY-180454	NUCC-0201642		/	Unkown
HY-181473	Antiproliferative agent-75		/	Unkown
HY-183004	NCP26		/	Unkown
HY-183474	LZZ-02	Inhibitor	/	Unkown
HY-N15201	Betavulgarin	Inhibitor	/	Unkown
HY-N15438	Herbacitrin	Inhibitor	/	Unkown
HY-RS18487	Nol3 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W806047	BRD4 Inhibitor-37		/	Unkown
HY-15594	Phen-DC3		/	Unkown

Inhibitory Antibodies (2)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P991432	VTX-0811		/	Unkown
HY-P990850	Anti-c-myc Antibody (9E10)	Inhibitor	99.39%	Unkown

Orthologs Information

Species	Symbol	Source	ID
Homo sapiens	Myc	NCBI	NCBI:4609